|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.875 SEK | +1.63% |
|
+1.08% | -1.32% |
| 07-20 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 07-16 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 455M 394M 368M 337M 634M 43.32B 644M 4.31B 1.69B 21.71B 1.71B 1.67B 71.77B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 423M 366M 342M 313M 590M 40.26B 599M 4.01B 1.57B 20.18B 1.59B 1.55B 66.71B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.63% | ||
| 1 week | +1.08% | ||
| Current month | +1.08% | ||
| 1 month | -20.21% | ||
| 3 months | -30.56% | ||
| 6 months | +1.35% | ||
| Current year | -1.32% |
| 1 week | 1.78 |  | 1.91 |
| 1 month | 1.61 | | 2.53 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 13.4 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/17/26 A | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 12/30/25 A | Buy | Chairman | 20,000 | 0.0082% | ||
| 12/27/25 A | Buy | Chairman | 5,500 | 0.0023% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.63% | +1.08% | -30.30% | -33.63% | 47.11M | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,062B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 619B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 431B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 358B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 293B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 247B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 219B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 200B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 162B | |
| Average | +1.34% | -0.68% | +28.50% | +41.26% | 359.23B | |
| Weighted average by Cap. | +1.12% | +0.49% | +48.59% | +75.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.42M 36.81M 33.77M 63.52M 4.34B 64.53M 432M 170M 2.17B 171M 167M 7.19B | 53.9M 46.63M 43.54M 39.94M 75.13M 5.13B 76.32M 511M 201M 2.57B 202M 198M 8.5B |
| Net income | -53.18M -46M -42.96M -39.41M -74.12M -5.06B -75.3M -504M -198M -2.54B -200M -195M -8.39B | -51.89M -44.88M -41.92M -38.45M -72.32M -4.94B -73.47M -492M -193M -2.48B -195M -191M -8.18B |
| Net Debt | -73.01M -63.15M -58.98M -54.1M -102M -6.95B -103M -692M -272M -3.48B -274M -268M -11.51B | -32.11M -27.78M -25.94M -23.79M -44.76M -3.06B -45.47M -304M -119M -1.53B -121M -118M -5.06B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | SEK 1.875 | +1.63% | 50,964 |
| 06/08/26 | SEK 1.845 | +0.54% | 57,243 |
| 05/08/26 | SEK 1.835 | -3.42% | 79,704 |
| 04/08/26 | SEK 1.900 | 0.00% | 21,962 |
| 03/08/26 | SEK 1.900 | +2.43% | 32,162 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
